News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Feb 25, 2022 A nonparametric approach to confidence intervals for concordance index and difference between correlated indices Read Now
Publication Feb 23, 2022 Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis Read Now
Publication Feb 23, 2022 Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease Read Now
Publication Feb 19, 2022 Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease Read Now
Publication Feb 15, 2022 Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn’s Disease: Systematic Review and Meta-Regression Read Now
